We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Withdraws Rule on Reporting Authorized Generic Drugs
FDA Withdraws Rule on Reporting Authorized Generic Drugs
February 13, 2009
The FDA withdrew its direct final rule requiring drugmakers to report information on authorized generics in NDA annual reports, delaying implementation of part of the FDA Amendments Act (FDAAA) and giving companies more time to prepare for the rule.